IFF Stock Recent News

Review International Flavors' (IFF) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock.

NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF) today announced that it has completed the divestiture of its nitrocellulose business, including Walsrode Industrial Park in lower Saxony, Germany, to Czechoslovak Group (CSG). The business manufactures nitrocellulose strictly for industrial purposes, serving customers primarily in coatings and printing inks, and had been part of IFF's Pharma Solutions business unit. “The divestiture of our nitrocellulose business builds upon our deleveraging journey an.

International Flavors & Fragrances Inc. IFF reported better-than-expected earnings for the first quarter, after the closing bell on Tuesday.

IFF expects sales between $10.6 billion and $10.9 billion for fiscal 2025.

International Flavors & Fragrances Inc. (IFF) Q1 2025 Earnings Call Transcript

While the top- and bottom-line numbers for International Flavors (IFF) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

International Flavors (IFF) came out with quarterly earnings of $1.20 per share, beating the Zacks Consensus Estimate of $1.12 per share. This compares to earnings of $1.13 per share a year ago.

NEW YORK--(BUSINESS WIRE)---- $IFF--IFF (NYSE: IFF) reported financial results for the first quarter ended March 31, 2025. First Quarter 2025 Consolidated Summary: Reported (GAAP)   Adjusted (Non-GAAP)1 Sales   Loss Before Taxes*   EPS   Operating EBITDA   Operating EBITDA Margin   EPS ex Amortization $2.8 B   $(994) M   $(3.98)   $578 M   20.3%   $1.20 * Impacted by an impairment of goodwill of $1.15B in Food Ingredients Management Commentary “IFF delivered solid first quarter results, driven by discip.

Roquette Announces a New Organization following the Acquisition of IFF Pharma Solutions The company launches two renewed and strengthened Business Groups, and appoints their new leaders Lille, May 5, 2025 – Roquette, a global leader in plant-based ingredients and pharmaceutical excipients for the health and nutrition sectors, announces today a new organization following the successful acquisition of IFF Pharma Solutions announced on May 1. The new organization is designed to enhance agility and customer responsiveness, positioning Roquette for long-term, sustainable growth.

NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF) announced today the commencement of tender offers to purchase for cash certain of its outstanding series of notes listed in the tables below (collectively, the “Notes”) for an aggregate purchase price, excluding accrued and unpaid interest, of up to $1.8 billion. Pool 1 Tender Offers Pool 1 Maximum Amount: $1.0 billion(1(a)) Title of Security CUSIP/ISIN Principal Amount Outstanding(in millions) Acceptance Priority Level(2) Series Tender Cap(3) U.S. Tre.